journal
Journals Current Pharmaceutical Biotech...

Current Pharmaceutical Biotechnology

https://read.qxmd.com/read/38623980/a-novel-approach-of-polyvinyl-alcohol-acrylic-acid-based-hydrogels-for-controlled-delivery-of-diclofenac-sodium
#1
JOURNAL ARTICLE
Muhammad Suhail, Syed Faisal Badshah, I-Hui Chiu, Arif Ullah, Arshad Khan, Hamid Ullah, Noorah Saleh Al-Sowayan, Ming-Jun Tsai, Pao-Chu Wu
AIM AND OBJECTIVE: The aim of this study was to prepare polyvinyl alcohol/acrylic acid (PVA/AA) hydrogels for the controlled release of diclofenac sodium and to develop PVA/AA hydrogels as controlled release carriers to overcome not only the side effects of diclofenac sodium but also sustain its release for an extended period. BACKGROUND: Diclofenac sodium is employed for relieving pain and fever. The half-life of diclofenac sodium is very short (1-2 h). Hence, multiple intakes of diclofenac sodium are required to maintain a constant pharmacological action...
April 15, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38616742/nanodelivery-approaches-of-phytoactives-for-skin-cancers-current-and-future-perspectives
#2
JOURNAL ARTICLE
Evren Algın Yapar, Merve Nur Özdemir, Meltem Ezgi Durgun, Özlem Akbal Dağıstan, Simona Cavalu, Yıldız Özsoy, Murat Kartal
In recent years, there has been an increase in skin cancers due to external factors, especially environmental factors, and studies on treatment alternatives have gained importance. Nanomaterials are common, from sunscreen formulas to formulations designed to treat skin cancers at various stages. Using bioactives has multiple effects in treating skin cancers, which provides many advantages. In this regard, many phytochemicals gain importance with their antioxidant, anti-proliferative, anti-inflammatory, antiangiogenic, and analgesic effects...
April 9, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38616741/sirna-mediated-knockdown-of-abcb1-enhances-the-efficacy-of-doxorubicin-and-vinorelbine-in-breast-cancer-cells
#3
JOURNAL ARTICLE
Zahra Abbasfard, Abbas Behzad-Behbahani, Banafshe Rastegari, Sirous Naeimi, Mehdi Moghanibashi, Fatemeh Safari
BACKGROUND: Breast cancer remains a leading cause of cancer-related deaths among women, primarily attributed to the formidable challenge of multidrug resistance, often driven by the overexpression of the ABCB1 gene. OBJECTIVE: This study aimed to assess the synergistic effects of siRNA, doxorubicin, and vinorelbine on ABCB1 gene expression and cell viability in doxorubicin-resistant MCF-7/ADR breast cancer cells, with siRNA targeting ABCB1 to reduce its expression and doxorubicin/ vinorelbine to eradicate cancer cells...
April 9, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38591206/exploring-the-therapeutic-potential-of-flavonoids-in-the-management-of-cancer
#4
JOURNAL ARTICLE
Sonia Singh, Riya Verma
Flavonoids are a class of polyphenolic compounds that can be classified into six distinct categories, namely isoflavonoids, flavanones, flavanols, flavonols, flavones, and anthocyanidins. These compounds are naturally occurring and can be found in a diverse range of plant species. Flavonoids, a class of bioactive compounds, are mostly obtained through the consumption of vegetables, fruits and plant-derived beverages such as wine, cocoa-based products and green tea. Flavonoids have been demonstrated to exhibit a diverse range of anticancer properties...
April 8, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38566389/nanoemulsions-a-delivery-system-in-the-making-for-tumor-targeting-therapeutics-evaluation-and-characterization-to-meet-clinical-challenges
#5
JOURNAL ARTICLE
Ravi Shankar, Prabhat Kumar Upadhyay, Manish Kumar
Cancer is a complex disease characterized by the uncontrolled and unregulated growth of cells followed by invasion and proliferation from the site of origin to other sites of the body. Conventional chemotherapy largely kills rapidly expanding and dividing cancer cells by impairing DNA synthesis and mitosis. It is associated with various types of adverse effects ranging from simple nausea and appetite loss to serious ones like bone marrow depression and compromised immunity etc., due to their non-selectivity and inability to differentiate...
April 2, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38566388/insulin-analogs-and-the-mode-of-insulin-delivery-recent-advances-and-challenges
#6
JOURNAL ARTICLE
Medha Bhagi, Jasmine Kaur, Arti Dhar, Audesh Bhat
Diabetes is a medical condition associated with impaired glucose regulation caused either due to insufficient insulin production or resistance to insulin (Type 2 diabetes, gestational diabetes) or the absence of insulin through the selective killing of beta cells in the pancreas (Type 1 diabetes). Irregular insulin production leads to various health complications. To prevent such complications, patients must adhere to medical recommendations before availing of any advanced insulin therapy(ies), considered productive for the treatment...
April 2, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38566387/a-comprehensive-review-on-nanoparticles-as-drug-delivery-system-and-their-role-for-management-of-hypertension
#7
JOURNAL ARTICLE
Prerna, Dinesh Chandra Bhatt, Khalid Basir Mir, Vikash Kumar, Sandeep Rathor
The current global epidemic of hypertension is not a disease in and of itself but rather a significant risk factor for serious cardiovascular conditions such as peripheral artery disease, heart failure, myocardial infarction, and stroke. Although many medications that work through various mechanisms of action are available on the market in conventional formulations to treat hypertension, these medications face significant difficulties with their bioavailability, dosing, and associated side effects, which significantly reduces the effectiveness of their therapeutic interventions...
April 2, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38566386/revolutionizing-wound-healing-unleashing-nanostructured-lipid-carriers-embodied-with-herbal-medicinal-plant
#8
JOURNAL ARTICLE
Aditya Jain, Shikha Yadav, Javed Khan
Wound healing is crucial for maintaining skin integrity and preventing complications from external threats. Various plants, such as Achillea millefolium, Aloe vera, Curcuma longa, Calendula officinalis, Camellia sinensis, Azadirachta indica, and Plantago, have demonstrated wound healing capabilities and have been used in herbal medicine for wound care. NLCs are second-generation lipid nanoparticles, blending solid and liquid lipids to improve medication loading and limit leakage. NLCs have been used in various applications, including cosmeceuticals, chemotherapy, gene therapy, and brain targeting...
April 1, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38561610/noncoding-rna-lipotherapeutics-a-promising-breakthrough-in-pulmonary-hypertension-treatment
#9
JOURNAL ARTICLE
Xuanyi Hu, Xinxin Lv, Lingzhu Zhang, Shan-Shan Li, Xin Jin
Pulmonary Hypertension (PH) is a complex cardiovascular disorder characterized by elevated blood pressure in the pulmonary arteries. Current therapeutic approaches for PH have limitations in addressing the underlying molecular mechanisms. This article explores the potential of noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs), delivered through Lipid-Based Nanoparticles (LNPs) as a novel treatment strategy. These ncRNAs play critical roles in regulating vascular function and are implicated in PH pathogenesis...
March 29, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38561608/protective-effects-of-curcumin-and-nanomicelle-curcumin-on-chlorpyrifos-induced-oxidative-damage-and-inflammation-in-the-uterus-ovary-and-brain-of-rats
#10
JOURNAL ARTICLE
Maryam Nazarian, Hamed Aramjoo, Babak Roshanravan, Saeed Samarghandian, Tahereh Farkhondeh
BACKGROUND AND AIMS: Chlorpyrifos (CPF), which is classified as an Organophosphorus Pesticide (OP), has been identified as a toxic agent for the reproductive system due to its capacity to induce oxidative stress and inflammation. Curcumin (CUR) has been reported as a natural antioxidant and anti-inflammatory agent that could combat toxicity in various tissues. This study aims to examine the protective effects of CUR and its nanoformulation against reproductive impairment induced by CPF...
March 29, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38561607/potential-serotonin-5-ht2a-receptor-agonist-of-psychoactive-components-of-silene-undulata-aiton-lc-ms-ms-admet-and-molecular-docking-studies
#11
JOURNAL ARTICLE
Maram B Alhawarri, Suleiman Olimat
BACKGROUND: Silene undulata is historically used for inducing vivid and prophetic lucid dreams, but limited information exists on its phytochemical composition and potential pharmacological properties. OBJECTIVE: This study aimed to investigate the phytochemical composition of S. undulata through LC-MS/MS analysis and explore its potential serotonergic activity, which could support and confirm the traditional use of S. undulata as a dream-inducing plant. METHODS: LC-MS/MS analysis was conducted on S...
March 29, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38561609/the-neem-limonoid-nimbolide-modulates-key-components-of-the-dna-damage-response-signalling-in-cellular-and-animal-models-of-oral-squamous-cell-carcinoma
#12
JOURNAL ARTICLE
Soundararajan Arvindh, Manashi Priyadarshini, Abdul Basit Baba, Veeran Veeravarmal, Rajakishore Mishra, Rupesh Dash, Siddavaram Nagini
BACKGROUND: A deregulated DNA damage response (DDR) network is implicated in cancer progression and therapy resistance. OBJECTIVE: The present study was designed to investigate whether nimbolide, an anticancer neem limonoid, targets key components of the DDR signalling pathway in cellular and animal models of oral squamous cell carcinoma (OSCC). METHODS: OSCC cells (SCC-4 and SCC-9), 7,12-dimethylbenz[a]anthracene (DMBA)-induced hamster buccal pouch (HBP) carcinoma model, chemoresistant OSCC patient-derived xenograft (PDX) model established in athymic nude mice, and tissue sections from patients with oral premalignant/malignant disease were used for the study...
March 28, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38551054/research-strategy-for-short-peptide-fusion-inhibitors-based-on-6-hb-core-structure-against-hiv-1-a-review
#13
JOURNAL ARTICLE
Guodong Liang, Yan Huang, Yanbai Tang, Lu Ga, Caixia Huo, Yuheng Ma, Yan Zhao, Heiya Na, Zhao Meng
Acquired Immune Deficiency Syndrome (AIDS) is a devastating infectious disease caused by the Human Immunodeficiency Virus type 1 (HIV-1). Enfuvirtide(T20) is the first HIV-1 fusion inhibitor for marketing, which plays an important role in AIDS treatment. However, in the clinical application process, T20 has several drawbacks, such as a high level of development of drug resistance, a short half-life in vivo, and rapid renal clearance, which severely limits the clinical application. Therefore, the development of novel fusion inhibitors to address T20 shortcomings has long been the research hotspot...
March 28, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38551053/targeted-drug-delivery-to-ace2-cells-using-engineered-extracellular-vesicles-a-potential-therapeutic-approach-for-covid-19
#14
JOURNAL ARTICLE
Yao Zhang, Sheng-Jiao Song, Jin He, Zhuo-Hua Zhao, Ke Zhang, Yuan Zhang, Xing Li
BACKGROUND: Extracellular vesicles (EVs) are emerging as potential drug carriers in the fight against COVID-19. This study investigates the ability of EVs as drug carriers to target SARS-CoV-2-infected cells. METHODS: EVs were modified using Xstamp technology to carry the virus's RBD, enhancing targeting ability to hACE2+ cells and improving drug delivery efficiency. Characterization confirmed EVs' suitability as drug carriers. For in vitro tests, A549, Caco-2, and 4T1 cells were used to assess the targeting specificity of EVRs (EVs with membrane-surface enriched RBD)...
March 28, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38523537/exploring-the-diagnostic-and-prognostic-predictive-values-of-ferroptosis-related-markers-in-lung-adenocarcinoma
#15
JOURNAL ARTICLE
Guoliang Mao, Wuqin Xu, Muhammad Jamil, Wei Zhang, Nanlin Jiao, Yinhua Liu
BACKGROUND: Lung Adenocarcinoma (LUAD), a common and aggressive form of lung cancer, poses significant treatment challenges due to its low survival rates. AIM: To better understand the role of ferroptosis driver genes in LUAD, this study aimed to explore their diagnostic and prognostic significance, as well as their impact on treatment approaches and tumor immune function in LUAD. METHOD: To accomplish the defined goals, a comprehensive methodology incorporating both in silico and wet lab experiments was employed...
March 20, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38486388/role-of-phytoactive-based-nanoformulation-for-the-treatment-of-arthritis
#16
JOURNAL ARTICLE
Shivendra Kumar, Kantrol Kumar Sahu, Mohit Agrawal, Kuldeep Singh, Sunam Saha
Joints and arthritic conditions are among the most dangerous illnesses that humans have ever encountered and it is even more worrying that there is no recognized treatment for arthritis. The researchers looked for safer alternatives, such as herbal medicines, because the traditional treatments used to treat severe joint inflammatory issues have several negative side effects. A ligand-coated nanomedicine can bind to receptors that are overexpressed by cells in chronically inflammatory tissues, increasing its efficacy and reducing its systemic side effects...
March 14, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38482615/intestinal-epithelial-cell-specific-knockout-of-mettl3-aggravates-intestinal-inflammation-in-clp-mice-by-weakening-the-intestinal-barrier
#17
JOURNAL ARTICLE
Hongzhou Shi, Jiahui Sun, Yaya Sun, Junjie Wu, Guangqing Jiang, Zhaiyue Xu, Xin Shi, Miao Fang
BACKGROUND: Many studies have demonstrated that the expression of methyltransferase- like 3 (METTL3) is altered in various inflammatory diseases. Its specific mechanistic role in the intestinal inflammatory response during sepsis remains limited and requires further investigation. OBJECTIVES: Explore the potential mechanism of METTL3 in the intestinal inflammatory response during sepsis. MATERIALS AND METHODS: Immunohistochemical analysis was utilized to detect the expression of METTL3 in the necrotic intestine of patients with intestinal necrosis and the small intestine of cecal ligation and puncture (CLP) mice...
March 13, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38482614/unlocking-the-potential-of-rna-nanoparticles-a-breakthrough-approach-to-overcoming-challenges-in-colon-cancer-treatment
#18
JOURNAL ARTICLE
Dipanjan Karati, Swarupananda Mukherjee, Biswajit Basu, KevinKumar Garala, Ayon Dutta, Bhupendra G Prajapati, Sankha Bhattacharya
Globally, one of the leading causes of cancer-related deaths is colon cancer. As this form of cancer has a tremendous potential to metastasize, effective treatment is complicated and sometimes impossible. Despite the improvement of conventional chemotherapy and the advent of targeted therapies, overcoming multi-drug resistance (MDR) and side effects remain significant challenges. As a therapeutic intervention for targeted gene silencing in cancer, RNA technology shows promise and certain RNA-based formulations are currently undergoing clinical studies...
March 13, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38482616/nano-delivery-of-silibinin-potentiate-the-induction-of-immunogenic-cell-death-icd-in-melanoma-cells
#19
JOURNAL ARTICLE
Mina Amiri, Sevda Jafari, Afsaneh Lavasanifar, Ommoleila Molavi, Soheila Montazersaheb
BACKGROUND: Induction of immunogenic cell death (ICD) in tumors can enhance antitumor immunity and modulate immunosuppression in the tumor microenvironment (TME). OBJECTIVE: In the current study, we investigated the effect of silibinin, a natural compound with anticancer activity, and its polymer-based nanoformulations on the induction of apoptosis and ICD in cancer cells. METHODS: Free and nanoparticulate silibinin were evaluated for their growth-inhibitory effects using an MTT assay...
March 12, 2024: Current Pharmaceutical Biotechnology
https://read.qxmd.com/read/38485676/biofilm-formation-in-mycobacterial-genus-mechanism-of-biofilm-formation-and-anti-mycobacterial-biofilm-agents
#20
JOURNAL ARTICLE
Sina Nasrollahian, Hassan Pourmoshtagh, Sahar Sabour, Nahal Hadi, Taher Azimi, Saeed Soleiman-Meigooni
Mycobacterium tuberculosis, Mycobacterium leprae, and non-tuberculous mycobacteria (NTM) are among the most significant human pathogens within the Mycobacterium genus. These pathogens can infect people who come into contact with biomaterials or have chronic illnesses. A characteristic pathogenic trait of mycobacteria is the development of biofilms, which involves several molecules, such as the GroEL1 chaperone, glycopeptidolipids, and shorter-chain mycolic acids. Bacterial behavior is influenced by nutrients, ions, and carbon sources, which also play a regulatory role in biofilm development...
March 11, 2024: Current Pharmaceutical Biotechnology
journal
journal
35110
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.